Brief: Aroa Biosurgery Posts FY22 Product Sales Guidance Of $30M-33M
25/05/2021 02:45
May 25 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* FY22 PRODUCT SALES GUIDANCE OF $30M-33M
* TOTAL REVENUE FOR FY21 WAS $22.3M
* NORMALISED LOSS BEFORE INCOME TAX FOR FY21 WAS $7.4M
* PRODUCT GROSS MARGINS EXPECTED TO IMPROVE IN H2 FY22
Source text for Eikon: ID:nASX8V2Yqc
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))